ArticleMultiple sclerosis journal - experimental, translational and clinical

Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.

Ricardo Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.